Novocure Net Working Capital vs Accounts Payable Analysis

NVCR Stock  USD 19.69  1.81  10.12%   
Novocure financial indicator trend analysis is infinitely more than just investigating Novocure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novocure is a good investment. Please check the relationship between Novocure Net Working Capital and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Net Working Capital vs Accounts Payable

Net Working Capital vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novocure Net Working Capital account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Novocure's Net Working Capital and Accounts Payable is 0.91. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Novocure, assuming nothing else is changed. The correlation between historical values of Novocure's Net Working Capital and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Novocure are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Working Capital i.e., Novocure's Net Working Capital and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.91
Relationship DirectionPositive 
Relationship StrengthVery Strong

Net Working Capital

Accounts Payable

An accounting item on the balance sheet that represents Novocure obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Novocure are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Novocure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.As of 11/28/2024, Selling General Administrative is likely to drop to about 87.6 M. In addition to that, Tax Provision is likely to drop to about 9.1 M
 2021 2022 2023 2024 (projected)
Interest Expense3.4M3.3M3.3M3.2M
Depreciation And Amortization10.3M10.6M11.0M7.8M

Novocure fundamental ratios Correlations

0.970.10.890.930.650.950.80.91-0.770.880.510.820.910.930.931.00.880.710.990.930.780.580.940.920.64
0.970.10.890.840.630.860.80.94-0.820.880.380.820.90.910.930.960.880.770.970.930.840.510.950.920.66
0.10.10.370.020.280.140.480.23-0.490.350.220.470.380.340.30.08-0.040.220.040.30.380.770.270.320.66
0.890.890.370.760.630.790.970.96-0.930.990.410.980.990.980.980.870.820.730.870.980.810.670.910.990.89
0.930.840.020.760.580.970.680.78-0.570.770.580.70.820.840.820.950.790.520.920.820.590.590.810.810.5
0.650.630.280.630.580.540.490.59-0.70.550.40.510.650.670.630.610.80.660.590.640.750.570.750.640.4
0.950.860.140.790.970.540.740.78-0.630.80.640.760.840.850.830.960.730.540.920.830.650.630.850.830.59
0.80.80.480.970.680.490.740.91-0.90.980.391.00.950.940.930.790.670.640.780.940.750.690.840.950.96
0.910.940.230.960.780.590.780.91-0.890.950.250.920.950.960.980.90.830.720.930.980.810.590.910.980.79
-0.77-0.82-0.49-0.93-0.57-0.7-0.63-0.9-0.89-0.89-0.24-0.91-0.88-0.88-0.88-0.73-0.77-0.71-0.75-0.88-0.93-0.62-0.92-0.89-0.88
0.880.880.350.990.770.550.80.980.95-0.890.420.990.980.980.980.870.770.680.870.980.760.660.880.990.9
0.510.380.220.410.580.40.640.390.25-0.240.420.410.50.490.430.520.360.390.390.440.220.50.40.440.32
0.820.820.470.980.70.510.761.00.92-0.910.990.410.970.950.950.810.690.660.80.950.760.70.860.960.95
0.910.90.380.990.820.650.840.950.95-0.880.980.50.971.00.990.90.810.730.890.990.770.730.90.990.86
0.930.910.340.980.840.670.850.940.96-0.880.980.490.951.00.990.920.840.750.90.990.780.710.910.990.83
0.930.930.30.980.820.630.830.930.98-0.880.980.430.950.990.990.920.830.740.921.00.780.660.911.00.83
1.00.960.080.870.950.610.960.790.9-0.730.870.520.810.90.920.920.850.680.990.920.740.570.920.910.62
0.880.88-0.040.820.790.80.730.670.83-0.770.770.360.690.810.840.830.850.780.860.830.770.410.880.830.48
0.710.770.220.730.520.660.540.640.72-0.710.680.390.660.730.750.740.680.780.660.740.690.530.720.740.5
0.990.970.040.870.920.590.920.780.93-0.750.870.390.80.890.90.920.990.860.660.920.760.530.920.910.62
0.930.930.30.980.820.640.830.940.98-0.880.980.440.950.990.991.00.920.830.740.920.790.670.911.00.83
0.780.840.380.810.590.750.650.750.81-0.930.760.220.760.770.780.780.740.770.690.760.790.550.930.790.72
0.580.510.770.670.590.570.630.690.59-0.620.660.50.70.730.710.660.570.410.530.530.670.550.610.670.7
0.940.950.270.910.810.750.850.840.91-0.920.880.40.860.90.910.910.920.880.720.920.910.930.610.920.74
0.920.920.320.990.810.640.830.950.98-0.890.990.440.960.990.991.00.910.830.740.911.00.790.670.920.84
0.640.660.660.890.50.40.590.960.79-0.880.90.320.950.860.830.830.620.480.50.620.830.720.70.740.84
Click cells to compare fundamentals

Novocure Account Relationship Matchups

Novocure fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets479.4M1.1B1.1B1.2B1.1B651.0M
Short Long Term Debt Total187.1M444.2M632.2M639.1M596.2M305.9M
Other Current Liab(1K)36.9M(17.8M)(18.0M)59.4M62.3M
Total Current Liabilities86.3M113.6M142.6M158.8M179.1M188.1M
Total Stockholder Equity217.8M476.5M410.5M441.2M362.5M279.7M
Other Liab11.7M17.6M11.2M7.4M8.5M8.8M
Net Tangible Assets217.8M476.5M410.5M441.2M507.3M267.8M
Property Plant And Equipment Net34.6M41.6M53.9M69.0M97.7M102.6M
Net Debt(13.8M)209.5M366.4M468.9M355.4M373.2M
Retained Earnings(650.9M)(631.1M)(685.9M)(778.5M)(985.5M)(936.2M)
Accounts Payable36.9M53.6M72.6M85.2M94.4M99.1M
Cash177.3M234.7M208.8M115.3M240.8M164.9M
Non Current Assets Total39.5M52.5M66.0M80.1M111.7M117.3M
Non Currrent Assets Other4.9M10.9M12.1M11.2M14.0M14.7M
Other Assets4.9M10.9M12.1M11.2M12.8M13.5M
Long Term Debt149.4M429.9M562.2M565.5M568.8M597.3M
Cash And Short Term Investments326.1M842.6M937.7M969.4M910.6M518.3M
Net Receivables88.1M96.7M110.6M112.2M61.2M59.3M
Common Stock Shares Outstanding97.2M108.9M103.4M104.7M106.4M96.1M
Short Term Investments148.8M607.9M728.9M854.1M669.8M353.5M
Liabilities And Stockholders Equity479.4M1.1B1.1B1.2B1.1B651.0M
Non Current Liabilities Total175.3M461.8M586.4M591.7M604.5M634.7M
Inventory23.7M27.4M24.4M29.4M38.2M23.2M
Other Current Assets1K32.7M807K6.7M24.4M25.6M
Other Stockholder Equity871.4M1.1B1.1B1.2B1.4B916.6M
Total Liab261.7M575.5M729.0M750.5M783.6M822.8M
Total Current Assets439.9M999.4M1.1B1.1B1.0B607.6M
Accumulated Other Comprehensive Income(2.8M)(3.8M)(3.2M)(2.4M)(5.5M)(5.2M)
Property Plant Equipment34.6M11.4M53.9M32.7M37.6M22.9M
Retained Earnings Total Equity(650.9M)(631.1M)(685.9M)(778.5M)(700.6M)(735.6M)
Current Deferred Revenue11.8M17.8M17.8M18.0M16.2M13.4M
Long Term Debt Total149.5M429.9M562.2M565.5M650.3M682.9M
Capital Surpluse871.4M1.1B1.1B1.2B1.4B1.0B
Non Current Liabilities Other182K31.9M166K148K18K17.1K
Net Invested Capital367.2M906.4M972.7M1.0B931.3M731.9M
Net Working Capital353.6M885.8M930.9M952.8M855.3M696.2M

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.